U.S. approves Pfizer vaccine storage for 2 weeks at higher temperature

The U.S. drug regulator said Thursday it will allow the coronavirus vaccine developed by Pfizer Inc. to be transported and stored for up to two weeks at conventional freezer temperatures instead of the ultracold conditions previously required."The alternative temperature for transportation and storage will help ease the burden of procuring ultralow cold storage equipment for vaccination sites and should help to get vaccine to more sites," the U.S. Food and Drug Administration said in a press release.Before Thursday's announcement, the FDA had required the vaccine to be kept in an ultracold …READ FULL ARTICLE